Diranersen Slows One Alzheimer's Score but Misses Its Dose Goal
A single subset's 26% slowing is fueling cure talk online, but the trial missed its dose-response goal and Biogen still needs a larger study before any patient can get this shot.
The news. The narrative. The timeline.
Bureau: Tokyo
A single subset's 26% slowing is fueling cure talk online, but the trial missed its dose-response goal and Biogen still needs a larger study before any patient can get this shot.
A sedative cut human metabolism 20 percent, but no one can safely rewarm a hibernating person, so the Mars-sleep future space feeds celebrate stays separated from the lab by unsolved problems.
Gus the T. rex set a $50.1M fossil record, but whether the skeleton counts as science depends on custody terms nobody has disclosed — not the price everyone is cheering.
Warm El Nino water is crowding juvenile great whites onto California beaches early, but the real hazard is a hooked shark on a fishing line, not a rising odds of being bitten.
A Guardian columnist saw one tradescantia refill in three weeks after pinching, but the method she bounds by node, species and season is what viral plant hacks strip away.